Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

Lilly ends $1.4bn deal with immuno-oncology biotech NextCure

Lilly paid $25m upfront on top of a $15m equity investment

- PMLiVE

Christie Anbar appointed global healthcare lead at Ruder Finn

Anbar will oversee the agency's entire healthcare business

- PMLiVE

RFA strengthens team with a host of hires and promotions

New hires coincide with continued growth

- PMLiVE

Keeping up the fight against HIV and using the lessons to tackle other threats

Danny Buckland interviews Gilead’s Mike Elliott

- PMLiVE

Kanga Health appoints new commercial director

Kellie Sharp brings almost two decades of experience to the role

Digital therapeutics and their impact on society

Head of Customer Experience Elisa del Galdo explores how healthcare technology can help chronic disease patients and asks what makes a good digital therapeutic?

Blue Latitude Health

- PMLiVE

Healthanuary?

Whether you are taking part in Dry January, Veganuary, or any other health regime, just keep going!

Page & Page Health

- PMLiVE

AbbVie lauds head-to-head win for Skyrizi versus Cosentyx

Outperformed rival across all primary and secondary endpoints

- PMLiVE

Nektar’s opioid analgesic slammed with FDA panel rejection

Panelists unanimously rejected use of the chronic back pain drug

- PMLiVE

Congenica launches new application Congenica Neuro

Provides faster analysis of epilepsy and neurodevelopmental disorders

- PMLiVE

Lilly extends range of cut-price insulins in the US

Announces discounts in response to increasing pricing criticism

- PMLiVE

NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata

Cost-effectiveness watchdog issues a round of draft and final guidance

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links